Search

Your search keyword '"Etra, Aaron"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Etra, Aaron" Remove constraint Author: "Etra, Aaron" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
25 results on '"Etra, Aaron"'

Search Results

1. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

2. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

3. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

4. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

5. A Day 14 Endpoint for Acute GVHD Clinical Trials

6. Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

7. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

8. Effective treatment of low-risk acute GVHD with itacitinib monotherapy

9. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

11. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

12. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

13. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

14. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

15. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd

16. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease

17. The utility of biomarkers in acute GVHD prognostication

18. Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy

20. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis

21. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)

23. 32 - De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd

24. Prognostic Value of Elafin in Acute Graft-Versus-Host Disease

25. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease

Catalog

Books, media, physical & digital resources